Adiponectin upregulates MiR-133a in cardiac hypertrophy through AMPK activation and reduced ERK1/2 phosphorylation

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Li, Ying ^a   Cai, Xiaojun ^a   Guan, Yuqing ^a   Wang, Lei ^a   Wang, Shuya ^b   Li, Yueyan ^a   Fu, Ying ^b   Gao, Xiaoyuan ^a   Su, Guohai ^a  

^a JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CONNECTIVE TISSUE GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LENTIVIRUS VECTOR; MICRORNA; MIR 133A; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; ADIPONECTIN RECEPTOR; MIRN133 MICRORNA, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; IN VITRO STUDY; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; RAT; UPREGULATION; ANIMAL; CARDIAC MUSCLE CELL; CARDIOMEGALY; CHEMICALLY INDUCED; DISEASE MODEL; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; LENTIVIRINAE; METABOLISM; PHOSPHORYLATION; PROCEDURES; SIGNAL TRANSDUCTION;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC VECTORS; LENTIVIRUS; MALE; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCYTES, CARDIAC; PHOSPHORYLATION; RATS; RECEPTORS, ADIPONECTIN; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC; UP-REGULATION;

EID: 84958998929     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148482     Document Type: Article

References (51)

1. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005; 120(1):15-20. doi: 10.1016/j.cell.2004. 12.035 PMID: 15652477.
2. Ambros V. The functions of animal microRNAs. Nature. 2004; 431(7006):350-5. doi: 10.1038/ nature02871 PMID: 15372042.
3. Yin X, Peng C, Ning W, Li C, Ren Z, Zhang J, et al. miR-30a downregulation aggravates pressure overload- induced cardiomyocyte hypertrophy. Molecular and cellular biochemistry. 2013; 379(1-2):1-6. doi: 10.1007/s11010-012-1552-z PMID: 23660952.
4. Wang J, Yang X. The function of miRNA in cardiac hypertrophy. Cellular and molecular life sciences: CMLS. 2012; 69(21):3561-70. doi: 10.1007/s00018-012-1126-y PMID: 22926414; PubMed Central PMCID: PMC3474911.
5. Luo X, Zhang H, Xiao J, Wang Z. Regulation of human cardiac ion channel genes bymicroRNAs: theoretical perspective and pathophysiological implications. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2010; 25(6):571-86. doi: 10.1159/000315076 PMID: 20511702.
6. Feng Y, Niu LL, Wei W, Zhang WY, Li XY, Cao JH, et al. A feedback circuit between miR-133 and the ERK1/2 pathway involving an exquisite mechanism for regulating myoblast proliferation and differentiation. Cell death & disease. 2013; 4:e934. doi: 10.1038/cddis.2013.462 PMID: 24287695; PubMed Central PMCID: PMC3847338.
7. Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes & development. 2008; 22(23):3242-54. doi: 10.1101/gad.1738708 PMID: 19015276; PubMed Central PMCID: PMC2600761.
8. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, et al. MicroRNA-133 controls cardiac hypertrophy. Nature medicine. 2007; 13(5):613-8. doi: 10.1038/nm1582 PMID: 17468766.
9. Luo J, Zhou J, Cheng Q, Zhou C, Ding Z. Role of microRNA-133a in epithelial ovarian cancer pathogenesis and progression. Oncology letters. 2014; 7(4):1043-8. doi: 10.3892/ol.2014.1841 PMID: 24944666; PubMed Central PMCID: PMC3961467.
10. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circulation research. 2009; 104(2):170-8, 6p following 8. doi: 10.1161/CIRCRESAHA. 108.182535 PMID: 19096030.
11. Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension. 2003; 42(3):231-4. doi: 10.1161/01.HYP. 0000083488.67550.B8 PMID: 12860835.
12. Chang J, Li Y, Huang Y, Lam KS, Hoo RL, Wong WT, et al. Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway. Diabetes. 2010; 59(11):2949-59. doi: 10.2337/db10-0582 PMID: 20802255; PubMed Central PMCID: PMC2963556.
13. Okamoto Y. Adiponectin provides cardiovascular protection in metabolic syndrome. Cardiology research and practice. 2011; 2011:313179. doi: 10.4061/2011/313179 PMID: 21318102; PubMed Central PMCID: PMC3034991.
14. Fang F, Liu GC, Kim C, Yassa R, Zhou J, Scholey JW. Adiponectin attenuates angiotensin II-induced oxidative stress in renal tubular cells through AMPK and cAMP-Epac signal transduction pathways. American journal of physiology Renal physiology. 2013; 304(11):F1366-74. doi: 10.1152/ajprenal. 00137.2012 PMID: 23535586.
15. Essick EE, Ouchi N, Wilson RM, Ohashi K, Ghobrial J, Shibata R, et al. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling. American journal of physiology Heart and circulatory physiology. 2011; 301(3):H984-93. doi: 10.1152/ajpheart.00428.2011 PMID: 21666115; PubMed Central PMCID: PMC3191107.
16. Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends in cardiovascular medicine. 2006; 16(5):141-6. doi: 10.1016/j.tcm.2006.03.001 PMID: 16781946; PubMed Central PMCID: PMC2749293.
17. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel DR, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nature medicine. 2004; 10(12):1384-9. doi: 10.1038/nm1137 PMID: 15558058; PubMed Central PMCID: PMC2828675.
18. Fujita K, Maeda N, Sonoda M, Ohashi K, Hibuse T, Nishizawa H, et al. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha. Arteriosclerosis, thrombosis, and vascular biology. 2008; 28(5):863-70. doi: 10.1161/ATVBAHA.107.156687 PMID: 18309113.
19. Cao T, Gao Z, Gu L, Chen M, Yang B, Cao K, et al. AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts. PloS one. 2014; 9(8):e103793. doi: 10.1371/journal.pone.0103793 PMID: 25099270; PubMed Central PMCID: PMC4123880.
20. Li H, Yao W, Irwin MG, Wang T, Wang S, Zhang L, et al. Adiponectin ameliorates hyperglycemiainduced cardiac hypertrophy and dysfunction by concomitantly activating Nrf2 and Brg1. Free radical biology & medicine. 2015; 84:311-21. doi: 10.1016/j.freeradbiomed.2015.03.007 PMID: 25795513.
21. Lee Y, Kim BK, Lim YH, Kim MK, Choi BY, Shin J. The relationship between adiponectin and left ventricular mass index varies with the risk of left ventricular hypertrophy. PloS one. 2013; 8(7):e70246. doi: 10.1371/journal.pone.0070246 PMID: 23894624; PubMed Central PMCID: PMC3722139.
22. Amin RH, Mathews ST, Alli A, Leff T. Endogenously produced adiponectin protects cardiomyocytes from hypertrophy by a PPARgamma-dependent autocrine mechanism. American journal of physiology Heart and circulatory physiology. 2010; 299(3):H690-8. doi: 10.1152/ajpheart.01032.2009 PMID: 20622112; PubMed Central PMCID: PMC2944479.
23. Koitabashi N, Arai M, Kogure S, Niwano K, Watanabe A, Aoki Y, et al. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension. 2007; 49(5):1120-7. doi: 10.1161/HYPERTENSIONAHA.106.077537 PMID: 17372041.
24. Morikawa H, Tamori A, Nishiguchi S, Enomoto M, Habu D, Kawada N, et al. Expression of connective tissue growth factor in the human liver with idiopathic portal hypertension. Molecular medicine. 2007; 13(5-6):240-5. doi: 10.2119/2006-00093.Morikawa PMID: 17622321; PubMed Central PMCID: PMC1906684.
25. Rosin NL, Falkenham A, Sopel MJ, Lee TD, Legare JF. Regulation and role of connective tissue growth factor in AngII-induced myocardial fibrosis. The American journal of pathology. 2013; 182(3):714-26. doi: 10.1016/j.ajpath.2012.11.014 PMID: 23287510.
26. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circulation research. 2010; 106(11):1675-80. doi: 10. 1161/CIRCRESAHA.110.217737 PMID: 20538689.
27. Wang B, Haldar SM, Lu Y, Ibrahim OA, Fisch S, Gray S, et al. The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts. Journal of molecular and cellular cardiology. 2008; 45(2):193-7. doi: 10.1016/j.yjmcc.2008.05.005 PMID: 18586263; PubMed Central PMCID: PMC2566509.
28. Li G, Xie Q, Shi Y, Li D, Zhang M, Jiang S, et al. Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats. The journal of gene medicine. 2006; 8(7):889-900. doi: 10.1002/jgm.894 PMID: 16652398.
29. Sriramula S, Haque M, Majid DS, Francis J. Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension. 2008; 51 (5):1345-51. doi: 10.1161/HYPERTENSIONAHA.107.102152 PMID: 18391105; PubMed Central PMCID: PMC2736909.
30. Chen T, Liu J, Li N, Wang S, Liu H, Li J, et al. Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD. PloS one. 2015; 10(3):e0118909. doi: 10. 1371/journal.pone.0118909 PMID: 25748450; PubMed Central PMCID: PMC4351969.
31. Li CB, Li XX, Chen YG, Zhang C, Zhang MX, Zhao XQ, et al. Effects and mechanisms of PPARalpha activator fenofibrate on myocardial remodelling in hypertension. Journal of cellular and molecular medicine. 2009; 13(11-12):4444-52. doi: 10.1111/j.1582-4934.2008.00484.x PMID: 18754816.
32. Li Y, Ma HL, Han L, Liu WY, Zhao BX, Zhang SL, et al. Novel ferrocenyl derivatives exert anti-cancer effect in human lung cancer cells in vitro via inducing G1-phase arrest and senescence. Acta pharmacologica Sinica. 2013; 34(7):960-8. doi: 10.1038/aps.2013.19 PMID: 23645009; PubMed Central PMCID: PMC4002608.
33. Konishi M, Haraguchi G, Ohigashi H, Ishihara T, Saito K, Nakano Y, et al. Adiponectin protects against doxorubicin-induced cardiomyopathy by anti-apoptotic effects through AMPK up-regulation. Cardiovascular research. 2011; 89(2):309-19. doi: 10.1093/cvr/cvq335 PMID: 20978005.
34. McCollum LT, Gallagher PE, Ann Tallant E. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1. American journal of physiology Heart and circulatory physiology. 2012; 302(3):H801-10. doi: 10.1152/ajpheart.00908.2011 PMID: 22140049; PubMed Central PMCID: PMC3353789.
35. Liu YL, Huang CC, Chang CC, Chou CY, Lin SY, Wang IK, et al. Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment. Cardiorenal medicine. 2015; 5(2):79-88. doi: 10.1159/000371454 PMID: 25999956; PubMed Central PMCID: PMC4427153.
36. Zhong L, Chiusa M, Cadar AG, Lin A, Samaras S, Davidson JM, et al. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy. Cardiovascular research. 2015; 106(2):261-71. doi: 10.1093/cvr/cvv108 PMID: 25770146; PubMed Central PMCID: PMC4481572.
37. Li L, Zhang ZG, Lei H, Wang C, Wu LP, Wang JY, et al. Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathway. PloS one. 2013; 8(1):e49915. doi: 10.1371/ journal.pone.0049915 PMID: 23349663; PubMed Central PMCID: PMC3551944.
38. Wen P, Song D, Ye H, Wu X, Jiang L, Tang B, et al. Circulating MiR-133a as a biomarker predicts cardiac hypertrophy in chronic hemodialysis patients. PloS one. 2014; 9(10):e103079. doi: 10.1371/ journal.pone.0103079 PMID: 25313674; PubMed Central PMCID: PMC4196728.
39. Castoldi G, Di Gioia CR, Bombardi C, Catalucci D, Corradi B, Gualazzi MG, et al. MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. Journal of cellular physiology. 2012; 227(2):850-6. doi: 10.1002/jcp.22939 PMID: 21769867.
40. Koutsoulidou A, Kyriakides TC, Papadimas GK, Christou Y, Kararizou E, Papanicolaou EZ, et al. Elevated Muscle-Specific miRNAs in Serum of Myotonic Dystrophy Patients Relate to Muscle Disease Progress. PloS one. 2015; 10(4):e0125341. doi: 10.1371/journal.pone.0125341 PMID: 25915631; PubMed Central PMCID: PMC4411125.
41. Sang HQ, Jiang ZM, Zhao QP, Xin F. MicroRNA-133a improves the cardiac function and fibrosis through inhibiting Akt in heart failure rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2015; 71:185-9. doi: 10.1016/j.biopha.2015.02.030 PMID: 25960234.
42. Drawnel FM, Wachten D, Molkentin JD, Maillet M, Aronsen JM, Swift F, et al. Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy. The Journal of cell biology. 2012; 199(5):783-98. doi: 10.1083/jcb.201111095 PMID: 23166348; PubMed Central PMCID: PMC3514786.
43. Myers R, Timofeyev V, Li N, Kim C, Ledford HA, Sirish P, et al. Feedback Mechanisms for Cardiac-Specific MicroRNAs and cAMP Signaling in Electrical Remodeling. Circulation Arrhythmia and electrophysiology. 2015; 8(4):942-50. doi: 10.1161/CIRCEP.114.002162 PMID: 25995211; PubMed Central PMCID: PMC4545299.
44. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, et al. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? The American journal of pathology. 2007; 170 (6):1831-40. doi: 10.2353/ajpath.2007.061170 PMID: 17525252; PubMed Central PMCID: PMC1899438.
45. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature. 2005; 436(7048):214-20. doi: 10.1038/nature03817 PMID: 15951802.
46. Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB, et al. An intragenic MEF2- dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(52):20844-9. doi: 10.1073/ pnas.0710558105 PMID: 18093911; PubMed Central PMCID: PMC2409229.
47. Tomas E, Tsao TS, Saha AK, Murrey HE, Zhang Cc C, Itani SI, et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proceedings of the National Academy of Sciences of the United States of America. 2002; 99(25):16309-13. doi: 10.1073/pnas.222657499 PMID: 12456889; PubMed Central PMCID: PMC138607.
48. Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes. 2003; 52(6):1355-63. PMID: 12765944.
49. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature medicine. 2002; 8 (11):1288-95. doi: 10.1038/nm788 PMID: 12368907.
50. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. The Journal of biological chemistry. 2004; 279(2):1304-9. doi: 10.1074/jbc.M310389200 PMID: 14557259; PubMed Central PMCID: PMC4374490.
51. Matkovich SJ, Wang W, Tu Y, Eschenbacher WH, Dorn LE, Condorelli G, et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circulation research. 2010; 106(1):166-75. doi: 10.1161/ CIRCRESAHA.109.202176 PMID: 19893015; PubMed Central PMCID: PMC2804031.